Case Evaluation

If your child was born with a developmental complication and you were taking Zoloft during pregnancy, you may have a case.

*min 3 characters
*invalid email
*min 7 characters

Tell Us Your Story

Any additional information you can provide will help us in our case evalaution process. This step is optional.


According to the FDA,

Zoloft and other SSRIs have been linked to serious developmental side effects in infants

Zoloft Recall

There has been a lot of publicity regarding Zoloft and its possible connection to birth defects.  Despite the connection, Zoloft has not been recalled and in fact may be safe for its prescribed use, for non-pregnant users. If you are pregnant and taking Zoloft you should speak to your doctor or physician about continued use of Zoloft. You may also want to speak with an attorney about filing a Zoloft lawsuit to seek compensation for injuries to you or your child that may have resulted from the use of Zoloft during your pregnancy.

Will a Zoloft recall be issued?

According to the FDA, Zoloft and other selective serotonin reuptake inhibitor (SSRI) medications have been linked to serious developmental side effects in infants such as atrial septal defect, ventricular septal defect and neonatal pulmonary hypertension; however, more data is needed before federal action can be taken.

In July 2006, the FDA updated all SSRI prescribing information to include warnings concerning the potential for fetal birth risks. The agency is currently analyzing study data and advises patients to talk with their doctor about the potential risks and benefits associated with taking Zoloft while pregnant.

Current Zoloft Safety Warnings

Zoloft currently carries label warnings that indicate the risk of serious side effects such as:

  • Neonatal persistent pulmonary hypertension
  • Serotonin syndrome, a life-threatening drug reaction
  • Risk of suicidal behavior

A study published in the British Journal of Medicine also connected Zoloft with the development of congenital heart defects and indicated that the use of the medication could double the risk of the condition occurring in infants.

More Info

Informational Pamphlet
Treatment Options